We are excited to share our latest insights into the increasing demand for dialysis in India, which is driven by the rising prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD). This overview explores the clinical landscape of kidney disease, the growing burden on healthcare infrastructure, and the expanding market for dialysis services and nephrology care.

India faces a rising dialysis demand, with approximately 220,000 new ESRD cases annually and a ~16% CKD prevalence, primarily driven by diabetes and hypertension. Chronic Kidney Disease (CKD) leads to progressive kidney failure, requiring dialysis as a critical treatment. Common causes include diabetic nephropathy, hypertensive nephropathy, and glomerular disorders, with symptoms such as fatigue, swelling, high blood pressure, and respiratory issues.

Diagnosis relies on GFR assessment, imaging, and biochemical tests. Dialysis treatment options include hemodialysis (HD), requiring specialized centers, and peritoneal dialysis (PD), a home-based alternative. India has ~5,000 dialysis centers and ~3,400 nephrologists, yet the increasing patient load highlights the need for expanded infrastructure, innovative treatment solutions, and greater accessibility to improve patient outcomes

Dialysis Market Growth: Global & Indian Perspectives
The global dialysis market is projected to grow from $96B in 2024 to $145B by 2029, at a CAGR of 8.6%, while the Indian dialysis market is set to expand from $2.3B to $3.4B at 8.1% CAGR. This growth is fueled by the increasing prevalence of CKD and ESRD, alongside rising demand for dialysis services.
Key Market Players

• Global Leaders: Baxter, Fresenius Medical Care, B. Braun, Nipro (equipment); Vygon, Renolit, Asahi Kasei, Nikkiso (consumables).

• Indian Players: Renalyx, Atlantic Biomedical, Diacare Solutions (equipment); Soxa, Browndove, Narang Medical (consumables); NephroPlus, Apollo Dialysis, DaVita (service providers).

With rising disease burden and increasing investment in dialysis infrastructure, market players must focus on scaling innovations, expanding access, and improving affordability to meet growing patient needs.

India’s Dialysis Market: A Growing Opportunity Amid Challenges
India’s dialysis market is witnessing robust growth, driven by the rising prevalence of chronic kidney disease (CKD)—a consequence of escalating diabetes, hypertension, and an aging population. Government initiatives, such as the Pradhan Mantri National Dialysis Programme (PMNDP), and technological advancements, including AI-enabled dialysis machines, are reshaping accessibility and treatment efficiency. Additionally, a sharp 85% increase in healthcare spending is fostering infrastructure development, signaling strong market potential.
 
However, critical barriers persist, creating white spaces for strategic intervention. Limited rural access forces 60% of patients to travel long distances, while a severe nephrologist shortage (3,340 vs. the required 40,000) strains service delivery. High treatment costs (~?2.4 lakh annually) and insufficient insurance coverage leave a large patient base underserved. Furthermore, a dialysis center deficit—with only 40,000 machines available for 34 million required sessions—underscores an urgent need for capacity expansion. For stakeholders, these gaps present high-impact opportunities: investments in affordable dialysis solutions, telemedicine-based nephrology care, localized service expansion, and public-private partnerships can bridge accessibility gaps while unlocking substantial market growth. As demand escalates, innovative, cost-effective models will define success in India’s evolving dialysis landscape

India’s Dialysis Market: Public Initiatives and Private Investments Fuel Growth
India’s dialysis ecosystem is rapidly evolving, with government-led initiatives significantly expanding access while private sector funding drives innovation and expansion.
Public Sector Push: Strengthening Accessibility

• Pradhan Mantri National Dialysis Programme (PMNDP): Now active in 35 states/UTs, with 7,129 dialysis machines providing free treatment to 2.14M patients.
• Ayushman Bharat – PMJAY: Covering dialysis costs for 107.4M vulnerable families, ensuring broader financial protection.
• Rashtriya Arogya Nidhi (RAN): Up to ?15L in financial aid for dialysis-related care in 13 government hospitals.
• State-Level Dialysis Programs: Kerala, Rajasthan, Maharashtra, and Tamil Nadu are pioneering state-driven initiatives, including free dialysis and home-based peritoneal dialysis support.

Private Sector Momentum: Investment-Backed Expansion

• NephroPlus: Raised US$ 103M (May 2024, Series F) to scale operations in India and globally.
• VitusCare: Secured US$ 2.7M (Jan 2024, Series B) to enhance kidney care innovations.
• DCDC Kidney Care: Received $9.68M (Dec 2024, Series D) from British International Investment to expand its dialysis network in India.
  
  

• The convergence of public funding, insurance expansion, and private capital infusion signals a maturing market with high growth potential. Investors, healthcare providers, and technology innovators have an opportunity to bridge gaps in rural access, affordability, and infrastructure—paving the way for scalable, patient-centric dialysis solutions 

•